203 related articles for article (PubMed ID: 29321566)
41. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease.
Padayachee ER; Whiteley CG
Biochim Biophys Acta; 2011 Dec; 1810(12):1136-40. PubMed ID: 21930189
[TBL] [Abstract][Full Text] [Related]
42. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
Matsuzaki K
Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
Zou K; Michikawa M
Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
[TBL] [Abstract][Full Text] [Related]
45. Glycation of Lys-16 and Arg-5 in amyloid-β and the presence of Cu
Fica-Contreras SM; Shuster SO; Durfee ND; Bowe GJK; Henning NJ; Hill SA; Vrla GD; Stillman DR; Suralik KM; Sandwick RK; Choi S
J Biol Inorg Chem; 2017 Dec; 22(8):1211-1222. PubMed ID: 29038915
[TBL] [Abstract][Full Text] [Related]
46. Glutamate carboxypeptidase II does not process amyloid-β peptide.
Sedlák F; Šácha P; Blechová M; Březinová A; Šafařík M; Šebestík J; Konvalinka J
FASEB J; 2013 Jul; 27(7):2626-32. PubMed ID: 23525279
[TBL] [Abstract][Full Text] [Related]
47. Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques.
Dhanavade MJ; Sonawane KD
Amino Acids; 2014 Aug; 46(8):1853-66. PubMed ID: 24729013
[TBL] [Abstract][Full Text] [Related]
48. Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
Silva CS; Eira J; Ribeiro CA; Oliveira Â; Sousa MM; Cardoso I; Liz MA
Neurobiol Aging; 2017 Nov; 59():10-14. PubMed ID: 28780366
[TBL] [Abstract][Full Text] [Related]
49. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
[TBL] [Abstract][Full Text] [Related]
50. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
[TBL] [Abstract][Full Text] [Related]
51. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
Drew SC; Barnham KJ
Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
[TBL] [Abstract][Full Text] [Related]
52. Comparison between the aggregation of human and rodent amyloid β-proteins in GM1 ganglioside clusters.
Ueno H; Yamaguchi T; Fukunaga S; Okada Y; Yano Y; Hoshino M; Matsuzaki K
Biochemistry; 2014 Dec; 53(48):7523-30. PubMed ID: 25399921
[TBL] [Abstract][Full Text] [Related]
53. Chemical modifications of amyloid-β(1-42) have a significant impact on the repertoire of brain amyloid-β(1-42) binding proteins.
Medvedev AE; Buneeva OA; Kopylov AT; Mitkevich VA; Kozin SA; Zgoda VG; Makarov AA
Biochimie; 2016; 128-129():55-8. PubMed ID: 27400251
[TBL] [Abstract][Full Text] [Related]
54. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
[TBL] [Abstract][Full Text] [Related]
55. N-Terminal Hypothesis for Alzheimer's Disease.
Murray B; Sharma B; Belfort G
ACS Chem Neurosci; 2017 Mar; 8(3):432-434. PubMed ID: 28186729
[TBL] [Abstract][Full Text] [Related]
56. Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.
Woodman ZL; Oppong SY; Cook S; Hooper NM; Schwager SL; Brandt WF; Ehlers MR; Sturrock ED
Biochem J; 2000 May; 347 Pt 3(Pt 3):711-8. PubMed ID: 10769174
[TBL] [Abstract][Full Text] [Related]
57. Cleavage of arginyl-arginine and lysyl-arginine from the C-terminus of pro-hormone peptides by human germinal angiotensin I-converting enzyme (ACE) and the C-domain of human somatic ACE.
Isaac RE; Williams TA; Sajid M; Corvol P; Coates D
Biochem J; 1997 Dec; 328 ( Pt 2)(Pt 2):587-91. PubMed ID: 9371719
[TBL] [Abstract][Full Text] [Related]
58. The catalytic domain of insulin-degrading enzyme forms a denaturant-resistant complex with amyloid beta peptide: implications for Alzheimer disease pathogenesis.
Llovera RE; de Tullio M; Alonso LG; Leissring MA; Kaufman SB; Roher AE; de Prat Gay G; Morelli L; Castaño EM
J Biol Chem; 2008 Jun; 283(25):17039-48. PubMed ID: 18411275
[TBL] [Abstract][Full Text] [Related]
59. Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta.
Atwood CS; Perry G; Zeng H; Kato Y; Jones WD; Ling KQ; Huang X; Moir RD; Wang D; Sayre LM; Smith MA; Chen SG; Bush AI
Biochemistry; 2004 Jan; 43(2):560-8. PubMed ID: 14717612
[TBL] [Abstract][Full Text] [Related]
60. Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.
Masuyer G; Douglas RG; Sturrock ED; Acharya KR
Sci Rep; 2015 Sep; 5():13742. PubMed ID: 26403559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]